• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The reproducibility of adenosine monophosphate bronchial challenges in mild, steroid-naive asthmatics.轻度、未使用过类固醇的哮喘患者中,单磷酸腺苷支气管激发试验的可重复性。
Br J Clin Pharmacol. 2008 Aug;66(2):261-5. doi: 10.1111/j.1365-2125.2008.03186.x. Epub 2008 May 27.
2
Exercise, methacholine, and adenosine 5'-monophosphate challenges in children with asthma: relation to severity of the disease.哮喘患儿的运动、乙酰甲胆碱及5'-单磷酸腺苷激发试验:与疾病严重程度的关系
Pediatr Pulmonol. 2000 Sep;30(3):207-14. doi: 10.1002/1099-0496(200009)30:3<207::aid-ppul5>3.0.co;2-z.
3
Adenosine monophosphate is not superior to histamine for bronchial provocation test for assessment of asthma control and symptoms.在评估哮喘控制情况和症状时,对于支气管激发试验,单磷酸腺苷并不优于组胺。
Clin Respir J. 2017 Jul;11(4):470-480. doi: 10.1111/crj.12360. Epub 2015 Sep 10.
4
Comparison of three inhaled non-steroidal anti-inflammatory drugs on the airway response to sodium metabisulphite and adenosine 5'-monophosphate challenge in asthma.三种吸入性非甾体抗炎药对哮喘患者气道对焦亚硫酸钠和5'-单磷酸腺苷激发反应的比较
Thorax. 1996 Aug;51(8):799-804. doi: 10.1136/thx.51.8.799.
5
Subsensitivity to bronchoprotection against adenosine monophosphate challenge following regular once-daily formoterol.在每日一次规律使用福莫特罗后,对单磷酸腺苷激发试验的支气管保护作用敏感性降低。
Eur Respir J. 1998 Sep;12(3):580-4. doi: 10.1183/09031936.98.12030580.
6
Effect of magnitude of airway responsiveness and therapy with inhaled corticosteroid on histamine tachyphylaxis in asthma.气道反应性程度及吸入性糖皮质激素治疗对哮喘中组胺快速减敏的影响。
Chest. 1994 May;105(5):1434-8. doi: 10.1378/chest.105.5.1434.
7
Selective inducible nitric oxide synthase inhibition has no effect on allergen challenge in asthma.选择性诱导型一氧化氮合酶抑制对哮喘中的变应原激发无影响。
Am J Respir Crit Care Med. 2007 Nov 15;176(10):988-93. doi: 10.1164/rccm.200704-588OC. Epub 2007 Aug 23.
8
Can exhaled nitric oxide be a surrogate marker of bronchial hyperresponsiveness to adenosine 5'-monophosphate in steroid-naive asthmatic children?呼出一氧化氮能否作为未使用过类固醇的哮喘儿童对5'-单磷酸腺苷支气管高反应性的替代标志物?
Clin Exp Allergy. 2015 Apr;45(4):758-66. doi: 10.1111/cea.12447.
9
The effect of challenge method on sensitivity and reactivity to adenosine 5'-monophosphate in subjects with suspected asthma.激发方法对疑似哮喘患者对5'-单磷酸腺苷的敏感性和反应性的影响。
Chest. 2006 Nov;130(5):1448-53. doi: 10.1378/chest.130.5.1448.
10
Duration of effect of single-dose inhaled fluticasone propionate on AMP-induced bronchoconstriction.单剂量吸入丙酸氟替卡松对AMP诱导的支气管收缩的作用持续时间。
Eur Respir J. 2004 Apr;23(4):559-64. doi: 10.1183/09031936.04.00043504.

引用本文的文献

1
Assessing the Effects of Changing Patterns of Inhaled Corticosteroid Dosing and Adherence with Fluticasone Furoate and Budesonide on Asthma Management.评估氟替卡松富马酸酯和布地奈德吸入性皮质类固醇剂量调整和用药依从性模式改变对哮喘管理的影响。
Adv Ther. 2023 Sep;40(9):4042-4059. doi: 10.1007/s12325-023-02585-z. Epub 2023 Jul 12.
2
Therapeutic index of inhaled corticosteroids in asthma: A dose-response comparison on airway hyperresponsiveness and adrenal axis suppression.吸入性糖皮质激素在哮喘中的治疗指数:气道高反应性与肾上腺轴抑制的剂量反应比较
Br J Clin Pharmacol. 2021 Feb;87(2):483-493. doi: 10.1111/bcp.14406. Epub 2020 Jun 17.
3
Pharmacodynamic Studies to Demonstrate Bioequivalence of Oral Inhalation Products.证明口服吸入制剂生物等效性的药效学研究。
AAPS J. 2015 May;17(3):758-68. doi: 10.1208/s12248-015-9735-7. Epub 2015 Feb 26.

本文引用的文献

1
Indirect bronchial hyper-responsiveness: the coming of age of a specific group of bronchial challenges.间接支气管高反应性:一类特定支气管激发试验的发展成熟
Clin Exp Allergy. 2005 Mar;35(3):250-61. doi: 10.1111/j.1365-2222.2005.02177.x.
2
Duration of effect of single-dose inhaled fluticasone propionate on AMP-induced bronchoconstriction.单剂量吸入丙酸氟替卡松对AMP诱导的支气管收缩的作用持续时间。
Eur Respir J. 2004 Apr;23(4):559-64. doi: 10.1183/09031936.04.00043504.
3
Add-on therapy with montelukast or formoterol in patients with the glycine-16 beta2-receptor genotype.对携带甘氨酸-16β2-受体基因型的患者加用孟鲁司特或福莫特罗进行治疗。
Br J Clin Pharmacol. 2003 Jul;56(1):104-11. doi: 10.1046/j.1365-2125.2003.01899.x.
4
Indirect airway challenges.间接气道激发试验
Eur Respir J. 2003 Jun;21(6):1050-68. doi: 10.1183/09031936.03.00008403.
5
Rapid effect of inhaled fluticasone propionate on airway responsiveness to adenosine 5'-monophosphate in mild asthma.吸入丙酸氟替卡松对轻度哮喘患者气道对5'-单磷酸腺苷反应性的快速作用
J Allergy Clin Immunol. 2002 Oct;110(4):603-6. doi: 10.1067/mai.2002.128486.
6
Mometasone furoate antagonizes AMP-induced bronchoconstriction in patients with mild asthma.糠酸莫米松可拮抗轻度哮喘患者中AMP诱导的支气管收缩。
J Allergy Clin Immunol. 2000 May;105(5):906-11. doi: 10.1067/mai.2000.105709.
7
A dose-dependent effect of the novel inhaled corticosteroid ciclesonide on airway responsiveness to adenosine-5'-monophosphate in asthmatic patients.新型吸入性皮质类固醇环索奈德对哮喘患者气道对5'-单磷酸腺苷反应性的剂量依赖性效应。
Am J Respir Crit Care Med. 1999 Jul;160(1):237-43. doi: 10.1164/ajrccm.160.1.9809046.
8
Circadian variation in airway responsiveness to methacholine, propranolol, and AMP in atopic asthmatic subjects.特应性哮喘患者气道对乙酰甲胆碱、普萘洛尔和 AMP 反应性的昼夜变化。
Am Rev Respir Dis. 1993 Mar;147(3):512-7. doi: 10.1164/ajrccm/147.3.512.
9
Airway refractoriness to adenosine 5'-monophosphate after repeated inhalation.反复吸入后气道对5'-单磷酸腺苷的反应性降低
J Allergy Clin Immunol. 1989 Jan;83(1):152-8. doi: 10.1016/0091-6749(89)90490-9.
10
The influence of refractoriness to adenosine 5'-monophosphate on allergen-provoked bronchoconstriction in asthma.5'-单磷酸腺苷难治性对哮喘中变应原诱发的支气管收缩的影响。
Am Rev Respir Dis. 1989 Aug;140(2):321-6. doi: 10.1164/ajrccm/140.2.321.

轻度、未使用过类固醇的哮喘患者中,单磷酸腺苷支气管激发试验的可重复性。

The reproducibility of adenosine monophosphate bronchial challenges in mild, steroid-naive asthmatics.

作者信息

Singh Dave, Fairwood Jennifer, Murdoch Robert, Weeks Amanda, Russell Paul, Roy Kay, Langley Steve, Woodcock Ashley

机构信息

North West Lung Research Centre, University of Manchester, South Manchester University Hospitals Trust, Manchester, UK.

出版信息

Br J Clin Pharmacol. 2008 Aug;66(2):261-5. doi: 10.1111/j.1365-2125.2008.03186.x. Epub 2008 May 27.

DOI:10.1111/j.1365-2125.2008.03186.x
PMID:18507658
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2492916/
Abstract

AIMS

Repeated adenosine monophosphate (AMP) challenges are used to assess drug efficacy in clinical trials of mild, steroid-naive asthmatics. Refractoriness has been reported after repeated challenges over short intervals. This study evaluated possible tachyphylaxis after repeated AMP challenges at 12 and 24 h in mild, steroid-naive asthmatics.

METHODS

This was an open, three-way crossover study. Twenty-six steroid-naive asthmatic subjects were randomized to the following AMP challenge regimens separated by 7-14 days: (A) challenge at 08.00 h, repeated 24 h later; (B) challenge at 08.00 h, repeated 12 and 24 h later; (C) challenge at 20.00 h, repeated 12 h later. Comparisons within day were assessed using 90% confidence intervals (CIs). Non-inferiority approach taken with 1 doubling concentration (DC) as a clinically relevant difference.

RESULTS

Regimen A: Significant increase in AMP reactivity at 24 h. Mean DC difference was 0.6 (90% CI 0.24, 0.96). Regimen B: No evidence of difference between AMP reactivity at 08.00 h and a repeated challenge 12 h later. Repeated challenge at 24 h caused a significant increase in provocation concentration (PC)(20) compared with 12 h (mean DC difference 0.48, 90% CI 0.02, 0.95) and 0 h (mean DC difference 0.82, 90% CI 0.49, 1.14 - the upper CI exceeds the criteria of 1 DC). Challenge regimen C: No difference between challenges; mean DC difference of 0.28 (90% CI -0.2, 0.76).

CONCLUSION

The small decline in AMP reactivity during repeated challenges was not consistently observed, and was small compared with the known effects of inhaled drugs.

摘要

目的

在轻度、未使用过类固醇的哮喘患者的临床试验中,反复进行单磷酸腺苷(AMP)激发试验用于评估药物疗效。有报道称在短时间间隔内反复激发后会出现不应性。本研究评估了轻度、未使用过类固醇的哮喘患者在12小时和24小时反复进行AMP激发试验后可能出现的快速减敏反应。

方法

这是一项开放性、三向交叉研究。26名未使用过类固醇的哮喘受试者被随机分为以下AMP激发试验方案,间隔7 - 14天:(A)08:00进行激发试验,24小时后重复;(B)08:00进行激发试验,12小时和24小时后重复;(C)20:00进行激发试验,12小时后重复。日内比较采用90%置信区间(CI)进行评估。采用非劣效性方法,将1倍加倍浓度(DC)作为临床相关差异。

结果

方案A:24小时时AMP反应性显著增加。平均DC差异为0.6(90%CI 0.24,0.96)。方案B:08:00时的AMP反应性与12小时后重复激发试验之间无差异证据。与12小时相比,24小时重复激发试验导致激发浓度(PC)(20)显著增加(平均DC差异0.48,90%CI 0.02,0.95),与0小时相比(平均DC差异0.82,90%CI 0.49,1.14 - 上CI超过1 DC标准)。激发试验方案C:两次激发试验之间无差异;平均DC差异为0.28(90%CI -0.2,0.76)。

结论

在反复激发试验期间,AMP反应性的小幅下降并非始终可见,并且与吸入药物的已知效果相比幅度较小。